Skip to main content
. Author manuscript; available in PMC: 2009 Oct 7.
Published in final edited form as: AIDS. 2008 Sep 12;22(14):1789–1798. doi: 10.1097/QAD.0b013e32830c481b

Fig. 2. Virologic responses through 48 weeks.

Fig. 2

Fig. 2

Fig. 2

Fig. 2

a) Proportion of patients with viral load (VL) <400 copies/mL and <50 copies/mL over time stratified by TPV/r treatment group; b) Virologic response (viral load [VL] <400 copies/mL) stratified by TPV/r treatment group and age group; c) Median decrease in viral load (VL, log10 copies/mL) over time stratified by TPV/r treatment group; d) Virologic response (viral load [VL] <400 copies/mL) based on LPV mutation score stratified by TPV/r treatment group.